for

Versos AI Launches the First End-to-End Solution for Preparing and Licensing Video Training Data for AI

SAINT JOHN, New Brunswick, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Versos AI Inc. today announced the launch of the Video…

3 months ago

World Class by Diageo Announces Its Top 20 Bartenders for India, Nepal & Sri Lanka

The top 100 competed in the Hop Scotch Challenge which encouraged them to use Johnnie Walker Black Label in three…

3 months ago

Seedance2ai.online Launches All-in-One Seedance 2.0 Video Creation Platform With Free Tier for Global Creators

LOS ANGELES, CA, Feb. 21, 2026 (GLOBE NEWSWIRE) -- Seedance2ai.online today announced the public launch of its video creation platform…

3 months ago

Thermobalancing therapy emerges as drug-free option for BPH, chronic prostatitis, back pain and kidney stones

Oxford, UK, Feb. 21, 2026 (GLOBE NEWSWIRE) -- Therapeutic Dr Allen’s Devices are designed to treat different chronic health conditions,…

3 months ago

U.S. Food and Drug Administration (FDA) Accepts Tevas New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-‘749) for the Once-Monthly Treatment of Schizophrenia in Adults

Olanzapine long-acting injectable (LAI) suspension (TEV-'749) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation1If…

3 months ago

VERSES Announces Filing of Quarterly Report on Form 10-Q for the Three and Nine-Months Ended December 31, 2025

February 20, 2026 19:11 ET  | Source: VERSES AI Inc. VANCOUVER, British Columbia, Feb. 20, 2026 (GLOBE NEWSWIRE) -- VERSES…

3 months ago

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares

DUBLIN, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics…

3 months ago

Not sure how to give wishes for the Year of the Horse? Let’s hear from CGs in Guangzhou

GUANGZHOU, China, Feb. 20, 2026 /PRNewswire/ -- A news report from South:   As we gallop into the Year of…

3 months ago

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease…

3 months ago

Frost & Sullivan: Nucleus Security Receives the 2025 Global Vulnerability Management Transformational Innovation Leadership Recognition for Excellence in AI-Powered Vulnerability Management

Frost & Sullivan recognizes this company for redefining vulnerability management through its AI-powered platform, data-agnostic architecture, and deeply integrated, automated…

3 months ago